Modelling of pharmaceutical residues in Australian sewage by quantities of use and fugacity calculations

Chemosphere

Volumn 54, Issue 3, 2004, Pages 355-367

  Khan, Stuart J ^a   Ongerth, Jerry E ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Biodegradation; Fugacity modelling; Partitioning; PhACs; Wastewater

Indexed keywords

METABOLITES; SEWAGE; SEWAGE TREATMENT;

FUGACITY CALCULATIONS;

DRUG PRODUCTS;

BIODEGRADATION; MODELING; PHARMACEUTICAL INDUSTRY; SEWAGE TREATMENT;

ARTICLE; AUSTRALIA; BIODEGRADATION; CALCULATION; CONCENTRATION (PARAMETERS); DRUG INDUSTRY; SEWAGE EFFLUENT; SEWAGE TREATMENT; THEORETICAL MODEL;

EID: 0348046367     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2003.07.001     Document Type: Article

References (34)

1. Australian Bureau of Statistics, 1999. Population by Age and Sex: Australian States and Territories, 3201.0, ABS, Canberra, p. 18.
2. Baronti, C., Curini, R., D'Ascenzo, G., Di Corcia, A., Gentili, A., Samperi, R., 2000. Monitoring natural and synthetic estrogens at activated sludge sewage treatment plants and in a receiving river water. Environ. Sci. Technol. 34 (24), 5059-5066.
3. Benet, L.Z., Kroetz, D.L., Sheiner, L.B., 1996. Pharmacokinetics. The dynamics of drug absorption, distribution and elimination. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, pp. 3-27.
4. Boethling, R.S., Howard, P.H., Meylan, W., Stiteler, W., Beaumann, J., Tirado, N., 1994. Group contribution method for predicting probability and rate of aerobic biodegradation. Environ. Sci. Technol. 28 (3), 459-465.
5. Christensen, F.M., 1998. Pharmaceuticals in the environment-a human risk? Regul. Toxicol. Pharmacol. 28 (3), 212-221.
6. Clark, B., Henry, J.G., Mackay, D., 1995. Fugacity analysis and model of organic chemical fate in a sewage treatment plant. Environ. Sci. Technol. 29 (6), 1488-1494.
7. Daughton, C.G., Ternes, T.A., 1999. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ. Health Perspect. 107 (Suppl. 6), 907-938.
8. Di Guardo, A., Calamari, D., Benfenati, E., Halling-Sorensen, B., Zuccato, E., Fanelli, R., 2001. Pharmaceuticals as environmental contaminants: modelling distribution and fate. In: Kümmerer, K. (Ed.), Pharmaceuticals in the Environment. Springer, Berlin, pp. 91-102.
9. Heberer, T., 2002. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 131 (1-2), 5-17.
10. Henschel, K.-P., Wenzel, A., Diedrich, M., Fliedner, A., 1997. Environmental hazard assessment of pharmaceuticals. Regul. Toxicol. Pharmacol. 25 (3), 220-225.
11. Huang, C.-H., Renew, J.E., Smeby, K.L., Pinkston, K.E., Sedlak, D.L., 2001. Assessment of potential antibiotic contaminants in water and preliminary occurrence analysis. Water Resour. Update (120), 30-40.
12. Khan, S.J., Ongerth, J.E. Occurrence and behaviour of pharmaceutically active compounds in Australian sewage, in preparation.
13. Kümmerer, K., 2001. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources-a review. Chemosphere 45 (6-7), 957-969.
14. Kümmerer, K., StegerHartmann, T., Meyer, M., 1997. Biodegradability of the anti-tumour agent ifosfamide and its occurrence in hospital effluents and communal sewage. Water Res. 31 (11), 2705-2710.
15. Kuspis, D.A., Krenzelok, E.P., 1996. What happens to expired medications? A survey of human medication. Vet. Hum. Toxicol. 38 (1), 48-49.
16. Meylan, W., 1993-2000. KOWWIN v. 1.66. Syracuse Research Corporation, Syracuse.
17. Meylan, W., 1994-1999. BIOWIN v. 4.00. Syracuse Research Corporation, Syracuse.
18. Meylan, W., 1994-2000. HENRYWIN v. 3.10. Syracuse Research Corporation, Syracuse.
19. Meylan, W., Howard, P.H., 1991. Bond contribution method for estimating Henry's law constants. Environ. Toxicol. Chem. 10 (10), 1283-1293.
20. Meylan, W., Howard, P.H., 1995. Atom/fragment contribution method for estimating octanol-water partition coefficients. J. Pharm. Sci. 84 (1), 83-92.
21. Moffat, A.C. (Ed.), 1986. Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids and Postmortem Material. London, Great Britain.
22. Möhle, E., Kempter, C., Kern, A., Metzger, J.W., 1999. Examination of the degradation of drugs in municipal sewage plants using liquid chromatography-electrospray mass spectrometry. Acta Hydrochim. Hydrobiol. 27 (6), 430-436.
23. Montforts, M.H.M.M., 2001. Regulatory and methodological aspects concerning the risk assessment for medicinal products; need for research. In: Kümmerer, K. (Ed.), Pharmaceuticals in the Environment. Springer, Berlin, pp. 159-174.
24. Scherrer, R.A., Howard, S.M., 1977. Use of distribution coefficients in quantitative structure-activity relationships. J. Med. Chem. 20 (1), 53-58.
25. Schowanek, D., Webb, S., 2002. Exposure simulation for pharmaceuticals in European surface waters with GREATER. Toxicol. Lett. 131 (1-2), 39-50.
26. Sedlak, D.L., Pinkston, K.E., 2001. Factors affecting the concentrations of pharmaceuticals released to the aquatic environment. Water Resour. Update (120), 56-64.
27. Shiu, W.-Y., Ma, K.-C., Varhanicková, D., Mackay, D., 1994. Chlorophenols and alkylphenols: a review and correlation of environmentally relevant properties and fate in an evaluative environment. Chemosphere 29 (6), 1155-1224.
28. Steger-Hartmann, T., Kummerer, K., Schecler, J., 1996. Trace analysis of the antineoplastics ifosfamide and cyclophosphamide in sewage water by two-step solid-phase extraction and gas-chromatography-mass spectrometry. J. Chromatogr. A 726 (1-2), 179-184.
29. Straub, J.O., 2002. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001. Toxicol. Lett. 131 (1-2), 137-143.
30. Stuer-Lauridsen, F., Birkved, M., Hansen, L.P., Lutzhoft, H.C., Halling-Sorensen, B., 2000. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 40 (7), 783-793.
31. Ternes, T.A., 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32 (11), 3245-3260.
32. United States Pharmacopeia, 2000. Drug Information for the Health Care Professional, 20th ed. Micromedex, Englewood, USA.
33. van Wezel, A.P., Jager, T., 2002. Comparison of two screening level risk assessment approaches for six disinfectants and pharmaceuticals. Chemosphere 47 (10), 1113-1128.
34. Yoshida, F., Topliss, J.G., 2000. QSAR model for drug human oral bioavailability. J. Med. Chem. 43 (13), 2575-2585.